| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 11029342 | European Journal of Cancer | 2018 | 10 Pages | 
Abstract
												The epidemiologic landscape of HPV-positive OPSCC is evolving, with a dramatic increase in the proportion of HPV-associated OPSCC among patients 70 years or older. HPV remains a powerful predictor of improved survival in elderly patients, but with less pronounced effect on older adults undergoing definitive RT.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Diana J. Lu, Michael Luu, Alain Mita, Kevin Scher, Stephen L. Shiao, Emi P. Yoshida, Mark P. Sittig, Jon Mallen-St Clair, Allen S. Ho, Zachary S. Zumsteg, 
											